#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine leiomyosarcoma Vitamin B12 deficiency Glomerulonephritis Hepatitis D Obesity Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Hypotransferrinaemia Aspergillus infection Pseudoxanthoma elasticum Polycythaemia vera Lip and/or oral cavity cancer Nephrotic syndrome Scedosporium infection Squamous cell carcinoma of the oral cavity Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma Hereditary motor and sensory neuropathy – Life with Disease Mast cell activation syndrome Mantle cell lymphoma stage II – Trials in Disease Pemphigus – Trials in Disease Hepatic angiosarcoma – Diagnostics Rett syndrome – Treatment Turner’s syndrome – Treatment Waldenstrom’s macroglobulinaemia – Diagnostics Arterial tortuosity syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pegaspargase Azilsartan Medoxomil Peginterferon Alfa-2A TIFCEMALIMAB Mercaptopurine VHB937 Mometasone Furoate Syn321 AMO959 Botulinum Toxin Type A NALOXEGOL Cocarboxylase Tetrahydrate Gimeracil Buprenorphine Nemvaleukin Alfa Human Coagulation Factor Viii Bi 1839100 Setanaxib Ads-010 YL201 More therapies…

    Learn about Your Condition

    Cerebral haemorrhage Pyelonephritis acute Muscle strain Haemophilia Cervix carcinoma stage II Brain cancer metastatic Macular degeneration Hyperparathyroidism primary BRAF gene mutation Diabetic retinal oedema C3 glomerulopathy Facial paresis Retinal neovascularisation Mucopolysaccharidosis II Duchenne muscular dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Cortisone
    • Hydrocortisone
    Norway

  • Study of Atezolizumab, Vinorelbine, and Cyclophosphamide for Patients with Advanced Triple Negative Breast Cancer Previously Treated with Anti-PD-L1/PD-1

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Atezolizumab
    • Cyclophosphamide Monohydrate
    • Vinorelbine
    Italy

  • Long-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Eplontersen
    Cyprus France Germany Italy Portugal Spain +1

  • Study on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant

    Recruiting

    3 1
    Investigated Drugs:
    • Mocravimod
    France Germany Italy Poland Romania Spain

  • Study on Darbepoetin Alfa for Reducing Brain Injury in Newborns with Perinatal Arterial Ischemic Stroke

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Darbepoetin Alfa
    The Netherlands

  • Study on the Effects of Nadroparin Calcium in Patients with Subarachnoid Hemorrhage

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Nadroparin Calcium
    The Netherlands
Previous Page
1 … 333 334 335 336 337 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!